ProCE Banner Activity


Current Challenges and Emerging Treatments for the Management of Resistant Hypertension


This on-demand webcast features expert faculty who review the most recent guideline recommendations and clinical trial evidence on the management of resistant hypertension, with a focus on emerging treatment options.

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Nurse Practitioners: 1.00 Nursing contact hours, includes 1.00 hour of pharmacotherapy credit

Released: January 18, 2023

Expiration: January 17, 2024

No longer available for credit.



Debbie Cohen

Debbie Cohen, MD

Professor of Medicine
Director of Hypertension
Division of Nephrology
Department of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania

John Giacona

John Giacona, PA-C

Physician Assistant
Hypertension Section
Cardiology Division
UT Southwestern Medical Center
Dallas, Texas

Laura Ross

Laura Ross, PA-C, MPAS, CLS, DipACLM, AACC

Director, Heart Disease Prevention and Lipid Clinic
Park Nicollet Heart and Vascular Center
St Louis Park, Minnesota

Provided by

ProCE Banner


This activity is supported by an educational grant from

Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC.


Academy of Physician Associates in Cardiology

ProCE Banner

Target Audience

NPs and PAs who care for patients with cardiovascular diseases.

Learning Objectives

After completing this activity, participants should be better able to:

  • Identify barriers to achieving blood pressure goals in patients with resistant hypertension 

  • Assess patients with uncontrolled blood pressure for resistant hypertension 

  • Discuss the rationale for targeting the endothelin system to manage hypertension 

  • Develop strategies to achieve blood pressure goals in patients with resistant hypertension based on the latest evidence, guideline recommendations, and patient-specific factors


All faculty and planners participating in continuing education activities sponsored by Partners for Advancing Clinical Education (PACE) are required to disclose all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PACE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Debbie Cohen, MD: consultant/advisor/speaker: Medtronic, Metavention, Recor.

John Giacona, MPAS, PA-C, has no relevant financial relationships to disclose.

Laura Ross, PA-C, has no relevant financial relationships to disclose.

The planners and content peer reviewers from Partners for Advancing Clinical Education, Practicing Clinicians Exchange, and the Academy of Physician Associates in Cardiology do not have any relevant financial relationships to disclose

Instructions for Credit

Learners wishing to earn CE/CME credit must:

  1. View the content in its entirety
  2. Relate the content material to the learning objectives
  3. Complete evaluation form

The estimated time to complete this activity is 1.00 hour.


The program has been made available online.


The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Partners for Advancing Clinical Education, Practicing Clinicians Exchange, and the Academy of Physician Associates in Cardiology, or any educational supporter.


Joint Accreditation Statement
Joint AccreditationIn support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and the Academy of Physician Associates in Cardiology (APAC). Partners for Advancing Clinical Education (PACE) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


ANCC Credit Designation
Nursing contact hours:
1.00, which includes 1.00 hours of pharmacology credit.


AAPA Credit Designation
Joint AccreditationPartners for Advancing Clinical Education (PACE) has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credits for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. Approval is valid until January 17, 2024 PAs should only claim credit commensurate with the extent of their participation.


IPCE Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.